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Abstract
Objectives—Clinical practice guidelines recommend ongoing testing (surveillance) for colorectal
cancer survivors because they remain at risk for both local recurrences and second primary tumors.
However, survivors often do not receive colorectal cancer surveillance. We used the Health Belief
Model (HBM) to identify health beliefs that predict intentions to obtain routine colonoscopies among
colorectal cancer survivors.
Methods—We completed telephone interviews with 277 colorectal cancer survivors who were
diagnosed four years earlier, between 2003 and 2005, in North Carolina. The interview measured
health beliefs, past preventive behaviors, and intentions to have a routine colonoscopy in the next
five years.
Results—In bivariate analyses, most HBM constructs were associated with intentions. In
multivariable analyses, greater perceived likelihood of colorectal cancer (OR=2.00, 95% CI=1.16–
3.44) was associated with greater intention to have a colonoscopy. Survivors who already had a
colonoscopy since diagnosis also had greater intentions of having a colonoscopy in the future
(OR=9.47, 95% CI=2.08–43.16).
Conclusions—Perceived likelihood of colorectal cancer is an important target for further study
and intervention to increase colorectal cancer surveillance among survivors. Other health beliefs
were unrelated to intentions, suggesting that the health beliefs of colorectal cancer survivors and
asymptomatic adults may differ due to the experience of cancer.
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Introduction
With an estimated 150,000 new cases in 2008, colorectal cancer is the third most common
cancer in US men and women.1 Because colorectal cancer survivors are at risk for both local
recurrences and second primary tumors,2 clinical practice guidelines recommend ongoing
testing (surveillance) for colorectal cancer. Although recommendations have varied regarding
the specific test (e.g., colonoscopy, sigmoidoscopy) and frequency of surveillance, all
guidelines published over the last decade recommend colorectal cancer surveillance to reduce
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the risk of mortality.3–11 In 2006, several organizations reached consensus that colorectal
cancer survivors should get routine colonoscopies 1 and 3 years after surgery, and then every
5 years.4
Regardless of the guideline used as a standard for adherence, colorectal cancer survivors do
not get adequate surveillance. Twenty-four to 40% do not receive colorectal cancer surveillance
three years after diagnosis;12–14 this rate is estimated at 20% to 35% within 5 years.13–15
Prior studies have identified clinical and demographic characteristics of survivors who are less
likely to receive colorectal cancer surveillance, including those who have rectal cancer (as
opposed to colon cancer),12, 14–16 are younger,12–17 and are white,12, 14, 18 although the
evidence for race is inconsistent.13, 15, 16 However, these risk factors are not mutable. To
develop effective strategies to increase surveillance, it is important to identify potentially
modifiable factors that can direct the content of an intervention.
The Health Belief Model (HBM) posits that individuals are more likely to engage in preventive
health behavior if they have higher perceived likelihood of getting the disease, higher perceived
severity of the disease, fewer perceived barriers to prevention, more perceived benefits of
prevention, higher self-efficacy, and have more cues to taking action.19 The HBM has been
used extensively to both predict screening behavior (including colorectal cancer) and design
interventions to increase screening.20–28 However, the HBM has not been applied to
colorectal cancer surveillance. This is critical because CRC survivors may differ from
asymptomatic patients on elements of the HBM.
Thus, in a cohort of CRC survivors, we hypothesized that higher perceived likelihood of CRC,
more perceived benefits to colonoscopy, fewer perceived barriers to colonoscopy, greater self-
efficacy, and more cues to action would be associated with intention to have colonoscopy in
the next 5 years. We had 3 secondary hypotheses. First, poor continuity of care would be
associated with underuse of preventive care among survivors.29–31 Second, survivors who had
undergone colorectal cancer screening before their colorectal cancer diagnosis would have
greater intentions to have a surveillance colonoscopy than those who did not. Finally, having




Data came from the Cancer Care Outcomes Research and Surveillance (CanCORS)
Consortium, a national, population-based cohort study of lung and colorectal cancer. Detailed
descriptions of CanCORS have been published elsewhere.32, 33 Briefly, patients diagnosed
with colorectal cancer or lung cancer from May 2003 through October 2005 were identified
from cancer registries at 8 study sites across the country. The present study was restricted to
CanCORS patients in North Carolina, using survey questions developed solely for this study.
Eligible participants for the present ancillary study included CanCORS participants from 33
counties in North Carolina who completed baseline and 1-year interviews, were diagnosed
with stage I-III colorectal cancer, were alive without metastasis, and were not undergoing
treatment for their original cancer. Participants who were unable to have colonoscopies (i.e.,
did not have enough remaining colon) were not eligible to participate.
Data sources
Data for this study came from three sources. First, for eligible participants providing informed
consent, medical record audits were conducted by abstractors trained by a central CanCORS
team to ascertain cancer-related medical visits and procedures. Specifically, data on clinical
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characteristics, disease status, vital status, demographics, treatments, diagnostic procedures,
and participation in clinical trials were collected. Second, baseline interviews with participants
were conducted approximately 4 months after diagnosis. These interviews assessed cancer care
decision making, symptoms, satisfaction with care, demographics, and other topics for which
survivors are an important source of information. Finally, follow-up interviews were conducted
approximately four years after diagnosis only for North Carolina CanCORS participants in this
ancillary study. These follow-up interviews assessed colorectal cancer surveillance, health
beliefs, and intentions to have colonoscopy in the future. This study was approved by the
University of North Carolina at Chapel Hill Institutional Review Board.
Dependent variables
Our outcome was reported intention to receive a colonoscopy in the next 5 years; this period
was chosen because all guidelines recommended that this cohort should have at least 1
colonoscopy in the next 5 years. Intention was chosen as an outcome because we were unable
to conduct a later assessment of actual colonoscopy use, and intention has been shown to be
strongly associated with behavior.34
To assess intentions, the interviewer described colonoscopies and then asked about the
participant’s expectation of having a colonoscopy, which was phrased as: “How likely are you
to have a colonoscopy in the next 5 years?” Response options ranged from 1 (extremely
unlikely) to 5 (extremely likely).
Independent variables: health beliefs
Perceived likelihood of getting colorectal cancer—We asked subjects “Assuming you
do NOT get colonoscopies at regular intervals, what do you think is your chance of getting
cancer in your colon or rectum again in your lifetime?” The wording was designed to include
both local recurrences and second primary colorectal cancers. Response options ranged from
1 = “no chance” to 5 = “certain to get it”.
Perceived benefits and barriers—Perceived benefits of, and barriers to, colonoscopy
were assessed by adapting validated scales of these attributes with respect to colorectal cancer
screening.26 The 9 benefit items asked about the effectiveness of colonoscopy and the benefits
of early detection. The barriers measures included 5 items that addressed concerns about
undergoing colonoscopy (including negative results) and structural barriers (e.g., cost,
transportation). The adaptations from the original measures reflect differences between
screening colonoscopy for asymptomatic adults and surveillance colonoscopy for colorectal
cancer survivors. The 5-point response scale for each item ranged from 1 (strongly disagree)
to 5 (strongly agree). Perceived benefits and perceived barriers each formed a reliable scale
(Cronbach’s alpha = 0.75 and 0.77, respectively), and each set of items was combined into an
averaged summary measure.
Self-efficacy—Participants were asked how confident they were that they could get a
colonoscopy when they are due for one (1 = “not at all confident” to 5 = “extremely confident”).
Cue to action—One item assessed whether, since having surgery, any physician
recommended that the participant receive routine colonoscopies; this item was scored as 1 (yes)
or 0 (no).
Independent variables: preventive behaviors
Screening history—Participants were asked whether they had received colorectal cancer
screening before being diagnosed with colorectal cancer using measures created and tested by
Vernon et al., with yes (1) and no (0) as response options.35
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Visit to primary care provider—Participants were asked whether or not they had seen a
primary care provider since being diagnosed with colorectal cancer (1=yes, 0=no).
Surveillance colonoscopy use—The interviewer asked participants if they had
undergone any colonoscopies since having surgery for colorectal cancer, using a measure
created and validated by Vernon et al. (1=yes, 0=no).35 Current guidelines suggest that
participants should have received at least one colonoscopy since having surgery for their
cancer.
Covariates
Other predictors of colonoscopy intentions included age, sex, education (up to and including
high school graduate or more than high school graduate), income (continuous in $10,000
increments), insurance status (yes/no), site of the tumor (colon or rectum), stage at diagnosis,
and severity of comorbidities. Using data abstracted from medical records, severity of
comorbidities was assigned as none, mild, moderate, or severe using the Adult Comorbidity
Evaluation (ACE-27) index.36–38 Stage at diagnosis was determined using collaborative
staging if available. If unavailable, stage was determined from the registry or medical records.
Analysis
For variables with missing data (shown in Table 1), we imputed missing data using an iterative
multivariable regression technique in Stata.39, 40 For all analyses, data were analyzed using
two-tailed tests, with p values less than 0.05 considered statistically significant, in Stata.41
Statistical significance of predictors for all logit and ordered logit tests was determined using
Wald Χ2 tests.42
Descriptive analyses—We measured the associations between intention and each health
belief, use of primary care, history of screening, and use of surveillance using bivariate models.
We used bivariate ordered logit models for the 5-category intention variable.
Main analysis—We assessed predictors of intention to undergo a colonoscopy using
multivariable ordered logit regression models for the 5-category intention variable. Covariates
included age, level of education, sex, race/ethnicity, severity of comorbidities, site of tumor,
stage at diagnosis, income, and whether the participant had any insurance. We report odds
ratios, 95% confidence intervals, and p values.
Results
Description of the sample
Three hundred forty-one participants completed the follow-up interview at 4 years post-
diagnosis, between April 2007 and September 2008 (Figure 1). Of these, 64 were excluded
from the analysis due to not having stage reported, being stage IV, or being stage 0 (N=40);
not having had surgery (N=18); or not having responded to the intention question (N=6),
yielding a final sample of 277 participants. Compared with participants who completed the
one-year interview (and were not diagnosed with stage 0 or stage IV disease or did not have
staging information), participants who completed the follow-up interview were more likely to
have colon cancer but were otherwise comparable. (Table 1)
Participants were interviewed a mean of 45 months since diagnosis (standard deviation [s.d.]
= 2.3 months) and a mean of 44 months since their primary cancer surgery (s.d. = 2.5 months).
Most (72%) survivors had colon (non-rectal) cancer; 53% were female; and 79% were white.
Virtually all (96%) had visited a primary care physician since their diagnosis, and 86% reported
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having had a colonoscopy since having surgery. Forty-eight percent reported that they had had
screening for colorectal cancer before being diagnosed (Table 1).
Levels of intentions and health beliefs
Intentions to have a colonoscopy were very high; 88% reported that they were extremely likely
to have a colonoscopy in the next 5 years. Participants strongly endorsed (mean = 4.72) benefits
of colonoscopy. In general, participants reported few barriers to getting colonoscopy (mean =
1.66). (Table 2) The cost of colonoscopy was the greatest barrier (mean = 2.13).
Survivors felt their chance of getting colorectal cancer was, on average, between slight and
moderate. However, they varied widely about their likelihood of getting colorectal cancer (s.d.
= 0.98); 39% felt there was a slight chance or no chance of getting colorectal cancer again,
whereas 28% felt there was a high chance or that they were certain they would get colorectal
cancer again.
Participants reported feeling quite confident that they could obtain a colonoscopy when they
were due (mean self-efficacy = 4.81). Ninety-two percent of participants reported that at least
one doctor recommended routine colonoscopies.
Primary Hypotheses: Health beliefs and intentions
In bivariate analyses, most health beliefs were associated with intention to have a colonoscopy.
Survivors who had higher perceived likelihood (OR=2.02, 95% CI = 1.29–3.18), greater
perceived benefits (OR = 2.54. 95% CI = 1.26–5.14), lower perceived barriers (OR=0.28, 95%
CI = 0.16–0.50), and a recommendation for a colonoscopy from a physician (OR=14.85, 95%
CI = 5.91–37.31) were more likely to have greater intentions to undergo colonoscopy. Self-
efficacy was not associated with intentions to have a colonoscopy in the future.
In multivariable analyses (Table 3), greater perceived likelihood of getting colorectal cancer
again was associated with higher expectations of receiving a colonoscopy (OR = 1.83, p <0.05).
Perception of barriers, perception of benefits, physician recommendation, and self-efficacy
were not associated with intentions.
Secondary hypotheses: Health care use and intentions
In bivariate analyses, having seen a primary care physician in the year since diagnosis was not
associated with expectations to have colonoscopies in the future. Those who had a colonoscopy
after diagnosis were more likely to have greater intentions to have a colonoscopy in the future
(OR = 10.33, 95% CI = 4.62–23.1). Having had screening before diagnosis was not associated
with intentions.
Similarly, in multivariable analyses, having seen a primary care physician since diagnosis and
having been screened before diagnosis were unrelated to participants’ surveillance intentions.
Those who had colonoscopy since surgery for their disease had greater intentions of having
colonoscopy in the future (OR=9.47, 95% CI = 2.08–43.16).
Discussion
Intentions and behavior
Although colorectal cancer survivors are at increased risk for a second primary cancer or a
local recurrence,2, 4 they often receive less surveillance than recommended.12–18, 43 Because
of their history of colorectal cancer, one might expect colorectal cancer survivors to hold beliefs
that would support surveillance. Using a population-based study of patients with recently
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diagnosed colorectal cancer, we used the HBM to identify potentially modifiable predictors of
long-term (4-year) colorectal cancer surveillance among colorectal cancer survivors.
Overall, participants expressed high intentions to receive colonoscopy in the next 5 years.
Given that these participants have already been diagnosed with, and successfully treated for,
colorectal cancer, it is not surprising that they would intend to engage in preventive behavior
in the future. However, this high level of intention and the high level of reported colonoscopy
use contrasts with the low rates of surveillance found in other studies.12–18 This may be because
our sample consists of survivors who have not had a second primary cancer and are well enough
and motivated to participate in three interviews during a 4-year period. In addition, most
participants were insured and did not perceive major barriers to colonoscopy.
Association of health beliefs and intentions
Perceived likelihood of recurrent or new colorectal cancer was an important predictor of
expectation to undergo colonoscopy. This association had not been investigated before among
cancer survivors. The few relevant studies suggest that survivors are concerned about
recurrence. A multi-state survey study found that 68% of colorectal cancer 1-year survivors
feel fearful that their illness will return,44 the top-ranked concern among a list of 29 concerns.
In another survey study of 96 colorectal cancer survivors who responded at variable times after
completion of their treatment, 92% of colorectal cancer survivors reported believing that they
were at risk for recurrence.45 Our finding suggests that this perceived risk of recurrence may
be related to later surveillance, although this association needs to be confirmed in a prospective
study.
Although the perceived likelihood of getting colorectal cancer was high in this study, we
observed substantial variation. Some survivors clearly underestimated their likelihood of
recurrent or new colorectal cancer; 8% reported having no chance of a recurrent colorectal
cancer, even if they were not to get regular colonoscopies. If perceived likelihood drives not
just intention but actual surveillance behavior, addressing this erroneous perception presents
a useful target for intervention. To take appropriate steps to protect themselves, survivors
should understand their risk and perceive that it is modifiable through their own actions.46,
47 A Cochrane review of interventions that use risk communication to help people make
informed decisions about screening found that tailored risk communications had a modest
effect on screening behavior.48
The cue to action assessed in this study – recommendation for a colonoscopy from a physician
– was unrelated to intentions in multivariable analyses. Physician recommendations have been
shown to be related to colonoscopy screening in previous studies.49–51 Our finding indicates
that a physician recommendation may not be necessary to influence intentions to have a
surveillance colonoscopy. The operationalization of cues to action has not been systematically
studied in the screening literature,19 nor in the surveillance literature, suggesting that physician
recommendations may not be the most relevant cue to action for survivors.
Other health beliefs that have been shown to predict colorectal cancer screening did not predict
surveillance intentions in multivariable analyses among our sample of survivors. The health
beliefs that have been shown to be associated with colorectal cancer screening include
perceived benefits of undergoing colorectal cancer screening23, 26, 52 (although effects are
mixed22, 25), perceived barriers to undergoing colorectal cancer screening,22, 25, 26, 52 and
self-efficacy.49, 52 Our null results may reflect a difference in the role of health beliefs between
screening in the general population and surveillance among colorectal cancer survivors. After
experiencing the diagnosis and treatment of cancer, barriers may seem minimal, benefits to
colonoscopy may seem obvious, and the task of getting a colonoscopy (after more invasive
treatments) may not seem insurmountable, causing a floor effect in perceived barriers and a
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ceiling effect in perceived benefits and self-efficacy. More sensitive measures may need to be
created to assess these variables among survivors.
Past behaviors and intentions
The other predictor of greater intentions to get a routine colonoscopy was having already had
at least one routine colonoscopy since diagnosis. Because this study excluded survivors who
were diagnosed with a second primary cancer or recurrence, any prior colonoscopy either had
normal results or indicated precancerous polyps that were presumably removed. It is therefore
not surprising that survivors who had both interest in and access to an earlier colonoscopy, and
which had yielded normal results or a reduction in future cancer risk, would report an
expectation to continue with preventive care.
Limitations and conclusions
There are several limitations of these findings. First, because the data are cross-sectional, we
cannot make causal statements about the association between health beliefs and intentions.
Second, intentions may not reflect actual behavior, although a meta-analysis of 10 meta-
analyses found that intentions strongly predict behaviors across studies.34 Additionally, a meta-
analysis by Webb and Sheeran of 47 experiments manipulating intentions showed that changes
in intention led to corresponding changes in behavior.53 Finally, this study was conducted in
a single state, in a highly insured population with high use of primary care, which may limit
its generalizability.
The National Cancer Institute and other organizations have prioritized research on cancer
survivorship to better assess long-term health services use and health outcomes.29 We extended
research on cancer behaviors from screening to surveillance among a diverse sample of
registry-ascertained colorectal cancer survivors. Because of their history of cancer, survivors
may evaluate benefits, barriers, likelihood of future disease, self-efficacy, and cues to action
differently from those encouraged to have cancer screening. Moreover, they are at greater risk
than the rest of the population for contracting a future colorectal cancer.
We found that among colorectal cancer survivors four years after diagnosis, perceived
likelihood of getting colorectal cancer again is associated with interest in ongoing routine
colonoscopies. To facilitate surveillance and improve poor adherence to colonoscopy
guidelines, it is important to identify drivers of colonoscopy utilization and pragmatic
interventions that capitalize on these findings.
Implications for Cancer Survivors
To maximize interest in surveillance, it may be useful to create interventions for survivors that
inform survivors of their continued risk of colorectal cancer. One such intervention is a
survivorship care plan, which was designed by the Institute of Medicine to communicate
important information to survivors as they navigate the transition between cancer care and
post-treatment care.29 Survivorship care plans contain information for survivors including a
summary of their cancer diagnosis and treatment, recommendations for future care, and
resources for cancer survivors. Survivorship care plans, which already are being developed
and disseminated, may be ideal platforms to communicate important information about risks
of second malignancies to cancer survivors in order to improve adherence to surveillance
guidelines.
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Flowchart of study participants
Note: CRC = colorectal cancer
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Table 1
Comparison of sample characteristics between 1-year and 4-year interviews
Characteristic 1-year interviewa (N=601) % 4-year interview (N=277) %
Age
 Less than 65 47 52
 65 or older 53 48
Income
 Less than $50,000 40 40







 Less than high school 35 42
























Saw a primary care provider in first year b - 96
Screening for CRC before diagnosis - 48
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Characteristic 1-year interviewa (N=601) % 4-year interview (N=277) %
Had colonoscopy since diagnosis - 86
Note: CRC = colorectal cancer. % = percentage of observations.
Percentages may not add to 100 due to rounding.
a
Both samples exclude participants with missing stage, stage 0 or stage IV disease.
b
Primary care visits, CRC screening, and colonoscopy after diagnosis were only assessed during 4-year interview.













Salz et al. Page 14
Table 2
Mean values of health beliefs
Health Belief N Mean (s.d.)
Perceived likelihood of getting CRC again if you do not get regular colonoscopies1 248 2.84 (0.98)
Perceived benefits summary score 2 275 4.72 (0.44)
Perceived barriers summary score2 277 1.66 (0.58)
Self-efficacy3
 How confident are you that you can get a colonoscopy when you are due? 275 4.80 (0.63)
N %
Cues to action
 Have any of your doctors recommended that you have a colonoscopy? 272 92%
Note: s.d. = standard deviation, CRC = colorectal cancer.
1
Response options were 1=no chance to 5=certain to get it
2
Response options were 1=strongly disagree to 5=strongly agree
3
Response options were 1= not at all confident to 5= extremely confident
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